Related Experiment Videos
[Recent advances in pharmacogenomics in oncology]
Jacques Robert1, Jacques Bonnet
1Université Victor Segalen, Institut Bergonié, Bordeaux, France.
Bulletin Du Cancer
|February 21, 2004
Summary
Molecular insights into oncogenesis and genomic data enable novel cancer therapies. Research correlates gene expression with chemotherapy response, aiming to personalize treatment for better patient outcomes.
Area of Science:
- Oncology
- Molecular Biology
- Genomics
Context:
- Advancements in understanding oncogenesis molecular mechanisms.
- Human genome sequencing and large-scale databases provide new research tools.
- Emerging strategies focus on targeting cancer-specific genetic alterations.
Purpose:
- To discover and evaluate novel molecular targets for cancer therapy.
- To individualize cancer chemotherapy based on tumor molecular characteristics.
- To identify patient subgroups likely to benefit from specific chemotherapies.
Summary:
- Leveraging molecular oncology and genomic data to identify new therapeutic targets.
- Utilizing in vitro models to correlate gene expression profiles with chemosensitivity.
- Developing personalized cancer treatment strategies through molecular profiling.
Impact:
- Potential for significant improvements in cancer treatment efficacy.
- Optimistic outlook for enhancing the therapeutic arsenal against cancer.
- Clinical trials are underway to validate molecular-based treatment approaches.